Acetylsalicylic acid in the treatment of cardiovascular and cerebrovascular diseases;Acetylsalisylsyre i behandlingen av kardiovaskulaere og cerebrovaskulaere sykdommer

Tidsskrift for den Norske Laegeforening

Volumn 117, Issue 30, 1997, Pages 4432-4436

  Landmark, K ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; PLACEBO; THROMBOXANE A2;

ANGINA PECTORIS; BLEEDING; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; DOSE RESPONSE; HEART INFARCTION; HUMAN; MORTALITY; REVIEW; STROKE; TRANSIENT ISCHEMIC ATTACK; UNSTABLE ANGINA PECTORIS;

ASPIRIN; CARDIOVASCULAR DISEASES; CEREBROVASCULAR DISORDERS; HUMANS; PLATELET AGGREGATION INHIBITORS;

EID: 0031470469     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Jack DB. One hundred years of aspirin. Lancet 1997; 350: 437-9.
2. 2 but not of systemic prostacyclin by controlled-release aspirin. N Engl J Med 1991; 325: 1137-41.
3. Patrono C. Aspirin as an antiplatelet drug. N Engl J Med 1994; 330: 1287-94.
4. Winther K, Husted SE, Vissinger H. Low dose acetylsalicylic acid in the antihrombotic treatment of patients with stable angina pectoris and acute coronary syndromes (unstable angina pectoris and acute myocardial infarction). Pharmacol Toxicol 1994; 74: 141-7.
5. Fitzgerald DJ, Roy L, Catella F, FitzGerald GA. Platelet activation in unstable coronary disease. N Engl J Med 1986; 315: 983-9.
6. Winther K, Gleerup G, Husted S. Do low and moderate doses of acetylsalicylic acid affect tissue plasminogen activator at rest and after exercise? Am J Cardiol 1994; 73: 703-5.
7. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy - I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994; 308: 81-106.
8. Ridker PM, Manson JE, Gaziano M, Buring JE, Hennekens CH. Low-dose aspirin therapy for chronic stable angina. A randomized, placebo-controlled clinical trial. Ann Intern Med 1991; 114: 835-9.
9. Juul-Möller S, Edvardsson N, Jahnmatz B, Rosén A, Sørensen S, Ömblus R, for the Swedish Angina Pectoris Aspirin Trial (SAPAT) Group. Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. Lancet 1992; 340: 1421-5.
10. Nyman I, Larsson H, Wallentin L and the Research Group on Instability in Coronary Artery Disease in Southeast Sweden. Prevention of serious cardiac events by low-dose aspirin in patients with silent myocardial ischaemia. Lancet 1992: 340: 497-501.
11. Harpaz D, Benderly M, Goldbourt U, Kishon Y, Behar S, for the Israeli BIP Study Group. Effect of aspirin on mortality in women with symptomatic or silent myocardial ischemia. Am J Cardiol 1996; 78: 1215-9.
12. Lewis Jr HD, Davis JW, Archibald DG, Steinke WE, Smitherman TC, Doherty JE et al. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study. N Engl J Med 1983; 309: 396-403.
13. Cairns, JA, Gent M, Singer J, Finnie KJ, Froggatt GM, Holder DA et al. Aspirin, sulfinpyrazone, or both in unstable angina. Results of an Canadian multicenter trial. N Engl J Med 1985; 313: 1369-75.
14. Théroux P, Ouimet H, McCans J, Latour J-G, Joly P, Lévy G et al. Aspirin, heparin, or both to treat acute unstable angina. N Engl J Med 1988; 319: 1105-11.
15. Oler A, Whooley MA, Oler J, Grady D. Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. A meta-analysis. JAMA 1996; 276: 811-5.
16. The RISC Group. Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. Lancet 1990; 336: 827-30.
17. Wallentin LC and the Research Group on Instability in Coronary Artery Disease in Southeast Sweden. Aspirin (75 mg/day) after an episode of unstable coronary artery disease: long-term effects on the risk for myocardial infarction, occurrence of severe angina and the need for revascularization. J Am Coll Cardiol 1991; 18: 1587-93.
18. Manson JE, Grobbee DE, Stampfer MJ, Taylor JO, Goldhaber SZ, Gaziano M et al. Aspirin in the primary prevention of angina pectoris in a randomized trial of United States physicians. Am J Med 1990; 89: 772-6.